SPX3,998.84-72.86 -1.79%
DIA340.03-4.71 -1.37%
IXIC11,239.94-221.56 -1.93%

Goldman Sachs Maintains Neutral on Dentsply Sirona, Lowers Price Target to $34

Benzinga · 11/16/2022 07:42
Goldman Sachs analyst Nathan Rich maintains Dentsply Sirona (NASDAQ:XRAY) with a Neutral and lowers the price target from $41 to $34.